Multiple roles of baicalin and baicalein in the regulation of colorectal cancer

Front Pharmacol. 2024 Feb 5:15:1264418. doi: 10.3389/fphar.2024.1264418. eCollection 2024.

Abstract

The prevalence of colorectal cancer is increasing worldwide, and despite advances in treatment, colorectal cancer (CRC) remains in the top three for mortality due to several issues, including drug resistance and low efficiency. There is increasing evidence that baicalin and baicalein, novel small molecule inhibitor extracts of the Chinese herb Scutellaria baicalensis, have better anti-colorectal cancer effects and are less likely to induce drug resistance in cancer cells. The present review article explains the anti-proliferative properties of baicalin and baicalein in the context of against CRC. Additionally, it explores the underlying mechanisms by which these compounds modulate diverse signaling pathways associated with apoptosis, cell proliferation, tumor angiogenesis, invasion, metastasis, and tumor microenvironment. Moreover, this review article highlights the inhibitory effect of colorectal inflammatory-cancer transformation and the near-term therapeutic strategy of using them as adjuvant agents in chemotherapy.

Keywords: apoptosis; baicalein; baicalin; colorectal cancer; signaling pathways.

Publication types

  • Review

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Supported by NationalNaturalScienceFoundationofChina (no: 82205072); Supported by Natural Science Foundation project of Sichuan Science and Technology Department (no: 2023NSFSC 1830).